Treating aRCC in Practice: Current and Future Perspectives

JÃ¼rgen Gschwend, MD, PhD of the Technical University of Munich School of Medicine and Viktor GrÃ¼nwald MD, PhD of the Hannover Medical School discuss Treating aRCC in Practice: Current and Future Perspectives at the Kidney Cancer European Symposium 2017.

Treating aRCC in Practice: Current and Future Perspectives

Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani

Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD

FDA grants accelerated approval to ponatinib (ICLUSIG®) with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

Treating aRCC in Practice: Current and Future Perspectives

Related Posts

Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani

Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD

FDA grants accelerated approval to ponatinib (ICLUSIG®) with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia